Cargando…

Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case()

Detalles Bibliográficos
Autores principales:	Gonzálvez Guardiola, Paula, Díez Ares, Jose Ángel, Peris Tomás, Nuria, Sebastián Tomás, Juan Carlos, Navarro Martínez, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AEC. Published by Elsevier España, S.L.U. 2021
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826138/ http://dx.doi.org/10.1016/j.cireng.2021.01.002

Ejemplares similares

Perforación intestinal en paciente COVID-19 en tratamiento con tocilizumab y corticoides. A propósito de un caso
por: Gonzálvez Guardiola, Paula, et al.
Publicado: (2021)

Superior mesenteric vein thrombosis as the only manifestation of SARS-CoV-2 infection()
por: Navarro-Martínez, Sergio, et al.
Publicado: (2022)

Trombosis de la vena mesentérica superior como única manifestación de la infección por SARS-CoV-2
por: Navarro-Martínez, Sergio, et al.
Publicado: (2022)

A Case of Abdominal Perforation in a COVID+ Patient Treated With Tocilizumab and Corticosteroids
por: Chaudhry, Bilal, et al.
Publicado: (2023)

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
por: González-Castro, A., et al.
Publicado: (2022)

Simultaneous Complex Incisional Hernia Repair and Bariatric Surgery for Obese Patients: a Case Series of a Single-Center Early Experience
por: Sebastián-Tomás, Juan Carlos, et al.
Publicado: (2021)

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Incidencia de la patología abdominal quirúrgica urgente durante la pandemia por SARS-CoV-2
por: Pérez-Rubio, Álvaro, et al.
Publicado: (2020)

Incidence of surgical abdominal emergencies during SARS-CoV-2 pandemic()
por: Pérez-Rubio, Álvaro, et al.
Publicado: (2020)

Tocilizumab in COVID-19: Beware the risk of intestinal perforation
por: Vikse, Jens, et al.
Publicado: (2020)

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
por: Rubio-Rivas, Manuel, et al.
Publicado: (2020)

Long‐term outcomes in corticosteroid‐refractory Graves' orbitopathy treated with tocilizumab
por: Moi, Laura, et al.
Publicado: (2021)

Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results
por: Sánchez-Martínez, Francesca, et al.
Publicado: (2021)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2021)

Tocilizumab as a possible cause of ischemic colitis()
por: Forneiro Pérez, Rocío, et al.
Publicado: (2021)

Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
por: Strangfeld, A, et al.
Publicado: (2017)

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
por: Rubio-Rivas, Manuel, et al.
Publicado: (2021)

A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
por: Coyle, Justin, et al.
Publicado: (2020)

A case of CLIPPERS syndrome responsive to tocilizumab
por: Rempe, Torge, et al.
Publicado: (2019)

Perforated Appendicitis: Is Laparoscopy Safe?
por: Tirabassi, Michael V., et al.
Publicado: (2004)

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
por: Jiménez-Brítez, Gustavo, et al.
Publicado: (2020)

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
por: Jiménez-Brítez, Gustavo, et al.
Publicado: (2020)

Case Study: A Patient with Asthma, Covid-19 Pneumonia and Cytokine Release Syndrome Treated with Corticosteroids and Tocilizumab
por: Schleicher, Gunter K, et al.
Publicado: (2020)

Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: a systematic review and meta-analysis
por: Lim, Phei Ching, et al.
Publicado: (2022)

Secondary Failure of Tocilizumab in Treating Elderly-Onset Rheumatoid Arthritis With Systemic Symptoms Complicated by Diverticulum Perforation
por: Takagi, Soshi, et al.
Publicado: (2022)

Tocilizumab/unspecified corticosteroids: Spinal epidural abscess: 2 case report
Publicado: (2020)

Laparoscopic Repair of Small Bowel Perforation
por: Sinha, Rajeev, et al.
Publicado: (2005)

Colonoscopic Perforation Management by Laparoendoscopy: An Algorithm
por: Makarawo, Tafadzwa Patrick, et al.
Publicado: (2014)

CORTICOSTEROIDS IN THE MANAGEMENT  OF PEDIATRIC EPILEPSIES
por: Prpić, Igor, et al.
Publicado: (2021)

Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A
por: Kawaguchi, Hoshimi, et al.
Publicado: (2017)

The Sixth Decision Regarding Perforated Duodenal Ulcer
por: Lagoo, Sandhya, et al.
Publicado: (2002)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
por: López-Medrano, Francisco, et al.
Publicado: (2021)

INTESTINAL PERFORATION CAUSED BY COVID-19
por: NAHAS, Sergio Carlos, et al.
Publicado: (2020)

Subfascial Endoscopic Perforator Surgery: New Life for an Old Procedure?
por: Kulbaski, Mark J., et al.
Publicado: (1997)

Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone
por: Belhassen-García, Moncef, et al.
Publicado: (2021)

Corticosteroids/tocilizumab: Reactivation of Mycobacterium tuberculosis following off-label therapy: case report
Publicado: (2020)

Tocilizumab-Induced Erythema Annulare Centrifugum
por: João, Ana Luísa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4tfngqf1a1hvbug4uqq5mp2bes